Тема: Прогностическая значимость интервала QT у пациентов с ХБП С5д

1. Барсук А.Л., Возова А.М., Малинок Е.В., Ловцова Л.В., Чуева Т.О. Оценка нетрадиционных факторов риска сердечно-сосудистой патологии у пациентов, находящихся на программном гемодиализе, и их медикаментозная коррекция // Современные технологии в медицине. - 2012. - № 4. - С. 171-175.
2. Бова А. А. Кардиоренальный синдром: современное состояние проблемы / А. А. Бова // Медицинские новости. – 2013. – № 6. – С. 4-7.
3. Бойцов С.А., Кухарчук В.В., Карпов Ю.А. и др. Субклинический атеросклероз как фактор риска сердечно-сосудистых осложнений // Кардиоваскулярная терапия и профилактика. – 2012. – №11 (3). – С.2-6.
4. Волгина Г.В. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности // Нефрология и диализ. — 2000. — Т. 1, №2. — С. 25-32.
5. Зелтынь-Абрамов Е.М. Потешкина Н.Г. Андрусев А.М. и соавт. Гемодиализ и сердце: вопросов больше, чем ответов. Нефрология и диализ. – 2016. – №18.– С.69-75.
6. Куршубадзе Э., Власенко М.А., Власенко О.А. Особенности ремоделирования миокарда левого желудочка у больных с хроническим кардиоренальным синдромом 4-го типа // Вісник ХНУ імені В. Н. Каразіна. — 2012. — № 998. — С. 33-39.
7. Макаров Е.В., Максудова, А.Н., Шакиров И.Д. Состояние сердечно-сосудистой системы у находящихся на программном гемодиализе // Практическая медицина. – 2015. - № 7. - С.124-129.
8. Оганов Р. Г. Cосудистая коморбидность: общие подходы к профилактике и лечению // Рациональная фармакотерапия в кардиологии. – 2015. - №11 (1). - С.4-7.
9. Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология. – 2005. - №9 (3). С.7–15.
10. Смирнов А.В. Системный подход к анализу кардиоренальных взаимоотношений как первый шаг на пути к нефрологии формата п4 // Нефрология. – 2011. - №15 (2). – С.11-19.
11. Смирнов А.В., Шилов Е.М., Добронравов В.А., Каюков И.Г., Бобкова И.Н., Швецов М.Ю., Цыгин А.Н., Шутов А.М. Национальные рекомендации. Хроническая болезнь почек: Основные принципы скрининга, диагностики, профилактики и подходы к лечению // Нефрология. – 2012. – №16 (1). – С.89-115.
12. Строков А.Г., Гуревич К.Я., Ильин А.П., Денисов А.Ю., Земченков А.Ю., Андрусев А.М., Шутов Е.В., Котенко О.Н., Злоказов В.Б. Лечение пациентов с хронической болезнью почек 5 стадии (ХБП 5) методами гемодиализа и гемодиафильтрации. Клинические рекомендации // Нефрология. – 2017. – №21 (3). – С.92-111.
13. Строков А.Г., Терехов В.А., Гаврилин В.А. и соавт. Интрадиализная артериальная гипотензия и ее профилактика при помощи мониторинга относительного объема крови // Нефрология и диализ. - 2010. - №12. – С.250-253.
14. Суворов А.В., Зубеева Г.Н., Суслова О.А. и др. Нарушение сердечного ритма у больных с терминальной хронической почечной недостаточностью как предиктор сердечно-сосудистого риска // Медицинский альманах. – 2011. – №3 (16). – С.162–164.
15. Шугушев Х.Х., Багова Ф.М., Аттаева М.Ж. Сердечно-сосудистая система и хроническая болезнь почек // Архив внутренней медицины. – 2012. №2. – С.56-59.
16. Alves M.T., Vilaça S.S., Carvalho M.D., Fernandes A.P., Dusse L.M.,
Gomes K.B. Resistance of dialyzed patients to erythropoietin // Rev Bras Hematol Hemoter. – 2015. - №37(3). – Р.190-197.
17. Аmann K., Rits E. Cardiac structure and function in renal disease // Curr Opin Nephrol Hypertens. – 1996. - №5. – P.102–106.
18. Atar I., Konas D., Acikel S., Kulah E., Atar A., Bozbas H., Gulmez O. et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients // Int J Cardiol. – 2006. – №106. – P.47–51.
19. Bacharova L., Estes H.E., Schocken D.D. et al. The 4th Report of the Working Group on ECG diagnosis of left ventricular hypertrophy // J Electrocardiol. – 2017. - №50. – P.11–15.
20. Banerjee D. Sudden cardiac death in hemodialysis: clinical epidemiology and mechanisms // J Electrocardiol. – 2016. – №49 (6). – P.843-847.
21. Bansal N., Xie D., Sha D., Appel L., Deo R., Feldman H. I., Go A. S. Cardiovascular events after new-onset atrial fibrillation in adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) study // Journal of the American Society of Nephrology. – 2018. - №29 (12). – P.2859-2869.
22. Bashaw S.M., Cruz D.N. Epidemiology of cardiorenal syndromes // Contrib Nephrol. – 2010. - №165. – P.68-82.
23. Bazett H.C. An analysis of the time‐relations of the electrocardiograms. Heart / Fridericia L.S. Die systolendauer im elektrokardiogramm bei normalen menschen und bei herzkranken // Acta Med Scand. – 1920. - №53. – Р.469-486.
24. Bleyer A.J., Hartman J., Brannon P.C., Reeves-Daniel A., Satko S.G., Russell G. Characteristics of sudden death in hemodialysis patients // Kidney Int. – 2006. - №69 (12). – P.68–73.
25. Boudoulas K.D., Triposkiadis F., Parissis J. et al. The Cardio-Renal Interrelationship //. A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders. Med Clin North Am – 2017. - №59(6). – Р.103-115.
26. Brown J.R., Cochran R.P., Leavitt B.J., et al. Multivariable prediction of renal insufficiency developing after cardiac surgery // Circulation. – 2007. - №116 (11). – P. I139–I143.
27. Brunori G., Viola B.F., Parrinello G. et al. DODE study. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study // Am J Kidney Dis. – 2007. – №49 (5). – P.569–580.
28. Buiten, M. S., de Bie, M. K., Rotmans, J. I., Gabreëls, B. A., van Dorp, W., Wolterbeek, R., van Erven, L. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients // Heart. – 2014. – №100. – P.685–690.
29. Carson R.C., Juszczak M., Davenport A., Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? // Clin J Am Soc Nephrol. – 2009. - №4 (10). – P.1611–1619.
30. Chandna S.M., Da Silva-Gane M., Marshall C., Warwicker P., Greenwood R.N., Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy // Nephrol Dial Transpl. – 2011. - №26 (5). – P.1608–1614.
31. Chang T.I., Friedman G.D., Green T. et al. Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study // J Hum Hypertens. - 2011. - №25 (2). – P.98-105.
32. Charytan D.M., Foley R., McCullough P.A. Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study // Clin J Am Soc Nephrol. – 2016. - №11(4). – Р.21-34.
33. Chávez-González E., Donoiu I. Utility of P-wave dispersion in the prediction of atrial fibrillation // Current Health Sciences Journal. – 2017. - №43 (1). – P.5-11.
34. Chen L.Y., Shen W.K. Epidemiology of atrial fibrillation: A current perspective // Heart Rhythm. – 2007. – №4. – P.1–6.
35. Cheng S., Keyes M.J., Larson M.G. et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block // JAMA. – 2009. – №301. – P.2571–2577.
36. Chuasuwan A., Kellum J.A. Cardio-renal syndrome type 3: epidemiology, pathophysiology and treatment // Semin Nephrol. – 2012. - №32 (1). –
P.31-39
37. Collins A.J., Foley R.N., Gilbertson D.T., Chen S.C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease // Kidney Int Suppl. – 2015. - №5(1). – Р.2–7.
38. Cozzolino M., Galassi A., Pivari F. et al. The cardiovascular burden in end-stage renal disease // Contrib Nephrol. – 2017. - №191. – Р.44-57.
39. De Bie M.K., Koopman M.G., Gaasbeek A. et al. Incremental prognostic value of an abnormal baseline spatial QRS-T angle in chronic dialysis patients // Europace. – 2013. – №15. – P.290–296.
40. Deo R., Shou H., Soliman E.Z. et al. Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD // J Am Soc Nephrol.- 2016. – №27. – P.559–569.
41. Di Iorio B., Bellasi A. QT interval in CKD and haemodialysis patients // Clinical Kidney Journal. – 2013. – P.137-143.
42. Ding L., Sun L., Wang F. et al. Clinical Significance of Platelet Volume and Other Platelet Parameters in Acute Myocardial Infarction and Stable Coronary Artery Disease // Arq Bras Cardiol. – 2019.
43. Drechsler C., Grootendorst D.C., Pilz S., Tomaschitz A., Krane V., Dekker F. et al. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie) // Kidney Dis. – 2011. - №58 (4). – P.599–607.
44. Dzau V.J., Antman E.M., Black H.R. et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease) // Circulation. – 2006. - №19. P.2850-2870.
45. Flueckiger P., Pastan S., Goyal A. et al. Associations of ECG interval prolongations with mortality among ESRD patients evaluated for renal transplantation // Ann Transplant. – 2013. – №19. – P. 257–268.
46. Flythe J.E., Curhan G.C., Brunelli S.M. Disentangling the ultrafiltration rate– mortality association: The respective roles of session length and weight gain // Clin J Am Soc Nephrol. – 2013. - №8. – P.1066–1067.
47. Foley R.N., Culleton B.F., Parfrey P.S. et al. Cardiac disease in diabetic end-stage renal disease // Diabetologia. – 1997. - №40. – P.1307-1312.
48. Foley R.N., Gilbertson D.T., Murray T., Collins A.J. Long interdialytic interval and mortality among patients receiving hemodialysis // Med. – 2011. - №365. – P.99–107.
49. Fox C.S., Matsushita K., Woodward M. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis // Lancet. – 2012. - №380. – Р.1662-1673.
50. Garcia-Donaire J.A., Ruilope L.M. Cardiovascular and Renal Links along the Cardiorenal Continuum // Int J Nephrol. – 2011. – P.2-14.
51. Genovesi S., Dossi C., Vigano` M.R. et al. Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. // Europace. – 2008. - №10. – P.771–777.
52. Genovesi S., Rossi E., Nava M. et al. A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval // Europace. – 2013. - №15. – P.1025–1033.
53. Grande A. Atrial fibrillation and dialysis. A convergence of risk factors //Rev Esp Cardiol. – 2006. – №59. – P.766–769.
54. Green D., Ritchie J.P., Abidin N. et al. The association of ECG and echocardiographic abnormalities with sudden cardiac death in a dialysis patient cohort // J Nephrol. – 2014. – №27. – P.81–86.
55. Gruberg L., Weissman N.J., Waksman R., et al. Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency // Am J Cardiol. – 2002. - №89 (1). – P.54–57.
56. Hage F.G., de Mattos A.M., Khamash H. et al. QT prolongation is an independent predictor of mortality in end-stage renal disease // Clin Cardiol – 2010. - №33. – P.361–366.
57. Hall J.E., Brands M.W., Shek E.W. Central role of the kidney and abnormal fluid volume control in hypertension // J Hum Hypertens. – 1996. - №10 (10). P.633–639.
58. Herzog C.A., Asinger R.W., Berger A.K. ey al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) // Kidney Int. – 2011. - №80. – P.572-586.
59. Herzog C.A., Mangrum J.M., Passman R. Sudden cardiac death and dialysis patients // Semin Dial. – 2008. - №21. – Р.300–307.
60. Hodges M.S., Salerno D., Erlinen D. Bazett's QT correction reviewed: evidence that a linear QT correction for heart rate is better // J Am Coll Cardiol. – 1983. - №1. – Р.694.
61. House A.A., Anand I., Bellomo R. et al. Cardio-renal syndrome type 4: epidemiology, pathophysiology and treatment // Semin Nephrol. – 2012. - №32 (1). – P.40-48.
62. Ismail Y., Kasmikha Z., Green H.L. et al. Cardio-renal syndrome type 1: epidemiology, pathophysiology and treatment // Semin Nephrol. – 2012. - №32 (1). – P.18-25.
63. Jaroszynski A.J., Glowniak A., Sodolski T. et al. Effect of haemodialysis on signal-averaged electrocardiogram P-wave parameters // Nephrol Dial Transplant. – 2006. – №21. – P.425–430.
64. Jois P., Mebazaa A. Cardio-renal syndrome type 2: epidemiology, pathophysiology and treatment // Semin Nephrol. – 2012. - №32 (1). – P.26-30.
65. Kalantar-Zadeh K., Rhee C.M., Chou J. et al. The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management // Kidney Int Rep. – 2017. - №2(2). – Р.271-281.
66. Karnik J.A., Young B.S., Lew N.L., Herget M., Dubinsky C., Lazarus J.M. et al. Cardiac arrest and sudden death in dialysis units // Kidney Int. – 2001. - №60 (1). – P.35–47.
67. Kestenbaum B., Rudser K.D., Shlipak M.G. et al. Kidney function, electrocardiographic findings, and cardiovascular events among older adults // Clin J Am Soc Nephrol. – 2007. – №2. – P.501–508.
68. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease // Kidney inter., Suppl. -2012. – №2. – P.59–70.
69. Kleiger R.E., Stein P.K., Bigger J.T. Heart rate variability: measurement and clinical utility // Ann Noninvasive Electrocardiol. – 2005. – №10. – P.88–101.
70. Korantzopoulos P.G., Goudevenos J.A. Atrial fibrillation in end-stage renal disease: an emerging problem // Kidney Int. – 2009. – №76. – P.247–249.
71. Korantzopoulos, P., Kokkoris, S., liu, T., Protopsaltis, I., Li, G., & Goudevenos, J. A. (2007). Atrial Fibrillation in End-Stage Renal Disease // Pacing and Clinical Electrophysiology. – 2007. - №30 (11). – P.1391–1397.
72. Korantzopoulos P., Kolettis T.M., Galaris D., Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation // Int J Cardiol. – 2007. – №115. – P.135–143.
73. Kovesdy, C. P., Regidor, D. L., Mehrotra, R. et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients // Clin J Am Soc Nephrol. -2007. - №2. – P.999-1007.
74. Krane V., Heinrich F., Meesmann M. et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis // Clin J Am Soc Nephrol. – 2009. №4. – P.394–400.
75. Linde C., Leclercq C., Rex S. et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study // J Am Coll Cardiol. – 2002. - №40. – P.111–118.
76. Liu T., Li G. Potential mechanisms between atrial dilatation and atrial fibrillation // Am Heart J. – 2006. – №151.
77. Liu T., Li G. Pulmonary vein dilatation: Another possible crosslink between left atrial enlargement and atrial fibrillation? // Int J Cardiol. - 2007. – P.4-9.
78. Lokesh S., Green S.R., Mathew T.K. et al. A comparative study of platelet parameters in end stage renal disease patients undergoing haemodialysis and healthy individuals // Int J Adv Med. – 2016. - №3(3). – Р.559-563.
79. Madias J.E., Narayan V. Augmentation of the amplitude of electrocardiographic QRS complexes immediately after hemodialysis: a study of 26 hemodialysis sessions of a single patient, aided by measurements of resistance, reactance, and impedance // J Electrocardiol. - 2003. – №36. – P.263–271.
80. Mahmoodi B.K., Matsushita K., Woodward M. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis // Lancet. – 2012. - №380. – Р.49-61.
81. Majima S., Tanaka M., Okada H. et al. The PR interval and QRS duration could be predictors of renal function decline //Atherosclerosis. – 2015. - №240. – P.105–109.
82. Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging // Kidney Int. – 2006. - №69 (10). – P.39–45.
83. Moe S.M., Chertow G.M., Parfrey P.S., Kubo Y., Block G.A., Correa-Rotter R., et al. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) // Trial. Circulation. – 2015. - №132. – P.27–39.
84. Mohammad Reza Khosoosi Niaki, Mehrdad Saravi, Farshid Oliaee, Roghayeh Akbari, Sepideh Noorkhomami, Seyed Hassan Bozorgi Rad, Kobra Fallahpoor, Mir Saeed Ramezani Changes in QT interval before and after hemodialysis // Caspian J Intern Med. - 2013. – №4 (1). – P. 590–594.
85. Myerburg R.J. Cardiac arrest and sudden cardiac death. Braunwals’s Heart Disease: A Textbook of Cardiovascular Medicine / Douglas P., Zipes, Peter Libby, Robert O. Bonow, Eugene Braunwald (eds) // Elsevier Saunders, Philadelphia, PA. -2005.
86. Nicholas S, Cohen D, Townsend R, Besarab A, Lin J, et al. Chronic kidney disease (CKD) clinical practice recommendations for primary care physicians and healthcare providers - a collaborative approach // Divisions of Nephrology and Hypertension and General Internal Medicine; Henry Ford Health System, Edition 6.0. - 2011. – P.13-23.
87. Ogawa T., Nitta K. Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients // Contrib Nephrol. – 2015. - №185. – Р.76-86.
88. O'Neal W.T., Singleton M.J., Roberts J.D. et al. Association Between QT-Interval Components and Sudden Cardiac Death: The ARIC Study (Atherosclerosis Risk in Communities) // Circ Arrhythm Electrophysiol. – 2017. - №10(10).
89. Pacilio, M., Minutolo, R., Garofalo, C., Liberti, M. E., Conte, G., & De Nicola, L. Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question // Journal of Nephrology. – 2015. – №29(2). – P.153–161.
90. Panicker G.K., Karnad D.R., Natekar M., et al. Intra- and interreader variability in QT interval measurement by tangent and threshold methods in a central electrocardiogram laboratory // J Electrocardiol. – 2009. - №42. – Р.348-352.
91. Parekh R.S., Plantinga L.C., Kao W.H., Meoni L.A., Jaar B.G., Fink N.E., et al. The association of sudden cardiac death with inflammation and other traditional risk factors // Kidney Int. – 2008. - №74 (10). – P.35–42.
92. Patel C.H., Antzelevich C.H. Pharmacological approach to the treatment of long and short QT syndromes // Pharmacology and Therapeutices. – 2008. - №118. – P.138-151.
93. Podrid P.J. Etiology and pathogenesis of atrial fibrillation / Kowey PR, Naccarelli GV (eds.) // Atrial Fibrillation. New York: Marcel Dekker. – 2005. – P.27–60.
94. Poulikakos D., Banerjee D., Malik M. Major arrhythmic events and T wave morphology descriptors in hemodialyzed patients // J Electrocardiol. – 2014. – №47. – P.240–243.
95. Poulikakos D., Malik M. Challenges of ECG monitoring and ECG interpretation in dialysis units // J Electrocardiol. – 2016. - №49. – P.855–859.
96. Priori S.G., Blomstrom-Lundqvist C., Mazzanti A. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death // Eur Heart J. – 2015. - №36 (41). – P.2793-867.
97. Pun P.H., Lehrich R.W., Honeycutt E.F., Herzog C.A., Middleton J.P. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics // Kidney Int. – 2011. - №79 (2). – P.18–27.
98. Pun P.H., Lehrich R.W., Smith S.R. et al. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics // Clin J Am Soc Nephrol. – 2007. - №2. – P.491-500.
99. Rautaharju P.M., Zhang Z.M., Prineas R., Heiss G. Assessment of prolonged QT and JT intervals in ventricular conduction defects // Am J Cardiol. – 2004. - №93. – Р.1017–1021.
100. Ravelli F. Mechano-electric feedback and atrial fibrillation // Prog Biophys Mol Biol. – 2003. – №82. – P.137–149.
101. Ronco C., House A.A., Haapio M.. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong / Ronco C. // Intensive Care Med. – 2008. – №34. – P.957–962.
102. Sagie A., Larson M.G., Goldberg R.J. et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) // Am J Cardiol. – 1992. - №70. – Р.797–801.
103. Sassi R., Cerutti S., Lombardi F. et al. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society // Europace. – 2015. – №17. – P.1341–1353.
104. Schreurs C.A., Algra A.M., Man S.C. et al. The spatial QRS-T angle in the Frank vectorcardiogram: accuracy of estimates derived from the 12-lead electrocardiogram // J Electrocardiol. – 2010. – №43. – P.294–301.
105. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure // NEJM. - 1999. -№341 (8). - P.577–585.
106. Schwartz P.J. Idiopathic long QT syndrome: progress and questions // Am Heart J. – 1985. - №109. – P.399-411.
107. Shin D.H., Rhee S.Y., Jeon H.J. et al. An Increase in Mean Platelet Volume/Platelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis Patients // PLoS One. – 2017. - №12(1).
108. Shiroshita-Takeshita A., Brundel BJJM, Nattel S. Atrial fibrillation: Basic mechanisms, remodeling and triggers // J Interv Card Electrophysiol. – 2005. – №13. – P.181–193.
109. Silva R.T., Martinelli Filho M., Peixoto Gde L. et al. Predictors of arrhythmic events detected by implantable loop recorders in renal transplant candidates // Arq Bras Cardiol. – 2015. – №105. – P.493–502.
110. Skampardoni, S., Poulikakos, D., Malik, M., Green, D., & Kalra, P. A. The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease // Nephrology Dialysis Transplantation. – 2018. - №10. – P.2-6.
111. Soni S.S., Ronco C., Pophale R. et al. Cardio-renal syndrome type 5: epidemiology, pathophysiology and treatment // Semin Nephrol. - 2012. - №32 (1). - P.49-56.
112. Strauss D.G., Mewton N., Verrier R.L. et al. Screening entire health system ECG databases to identify patients at increased risk of death // Circ Arrhythm Electrophysiol. – 2013. – №6. – P.31-42.
113. Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy // Nephrology. – 2006. – №11. – P.36–41.
114. Szabo Z., Kakuk G., Fulop T., Matyus J., Balla J., Karpati I., Juhasz A. et al. Effects of haemodialysis on maximum P wave duration and P wave dispersion // Nephrol Dial Transplant. – 2002. – №17. – P.634– 1638.
115. Tereshchenko L.G., Kim E.D., Oehler A. et al. Electrophysiologic substrate and risk of mortality in incident hemodialysis // J Am Soc Nephrol. – 2016. – №27. – P.3413–3420.
116. United States Renal Data Sestem. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States / National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2013.
117. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. National Institutes of Health // National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. - 2010.
118. Vazquez-Ruiz de Castroviejo E., Sanchez-Perales C., Lozano-Cabezas C., Garcia-Cortes M.J., Guzman-Herrera M., Borrego-Utiel F., LopezLopez J. et al. Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study // Rev Esp Cardiol. – 2006. – №59. – P.779–784.
119. Waks J.W., Sitlani C.M., Soliman E.Z. et al. Global electric heterogeneity risk score for prediction of sudden cardiac death in the general population: the atherosclerosis risk in communities (ARIC) and cardiovascular health (CHS) studies // Circulation. – 2016. - №133. – Р.2222-2234.
120. Wu V.C., Lin L.Y., Wu K.D. QT interval dispersion in dialysis patients // Nephrology (Carlton). – 2005. - №10(2). – Р.109-112.
121. Zabel M., Malik M. Morphological assessment of T wave patterns (chapter 35) / Malik M, Camm AJ (eds) // Dynamic electrocardiography WileyBlackwell. – 2004. – P.305–357.
122. Zhang X., Zhu Q., Zhu L. et al. Spatial/frontal QRS-T angle predicts all-cause mortality and cardiac mortality: a meta-analysis // PLoS One. – 2015. – №10. – P.34-43.

Купить